MedPath

APO-LEVOCARB

APO-LEVOCARB

Approved
DIN Number

02195933

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02195933
AIG Number0210315002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:36.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

CARBIDOPAActive
Strength: 10 MG
Monograph: CARBIDOPA
LEVODOPAActive
Strength: 100 MG
Monograph: LEVODOPA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.